JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5776
Entravision Communication
EVC
$657M
| $41K | ﹤0.01% |
25,004
-1,129,630
| -98% | -$3.73M |
2017 Q1
28 quarters
|
|
5777
Protalix BioTherapeutics
PLX
$218M
| $41K | ﹤0.01% |
32,518
-11,216
| -26% | -$16.7K |
2023 Q2
3 quarters
|
|
5778
First Northwest Bancorp
FNWB
$93.6M
| $40.9K | ﹤0.01% |
2,614
-1,917
| -42% | -$28.6K |
2021 Q4
9 quarters
|
|
5779
Nuveen ESG International Developed Markets Equity ETF
NUDM
$734M
| $40.8K | ﹤0.01% |
1,313
| – | – |
2023 Q1
4 quarters
|
|
|
LVRO
5780
DELISTED
Lavoro
LVRO
| $40.7K | ﹤0.01% |
6,000
| – | – |
2023 Q1
4 quarters
|
|
|
SLNO
5781
DELISTED
Soleno Therapeutics
SLNO
| $40.6K | ﹤0.01% |
948
+267
| +39% | +$12.1K |
2020 Q2
15 quarters
|
|
|
DNMR
5782
DELISTED
Danimer Scientific, Inc.
DNMR
| $40.4K | ﹤0.01% |
927
-510
| -35% | -$21.1K |
2021 Q1
12 quarters
|
|
5783
CALL
Upstart Holdings
UPST
$2.37B
| $40.3K | ﹤0.01% |
1,500
+1,400
| +1,400% | +$41.4K |
2023 Q3
2 quarters
|
|
5784
Karooooo
KARO
$1.88B
| $40.3K | ﹤0.01% |
1,608
+744
| +86% | +$18.6K |
2023 Q3
2 quarters
|
|
|
LUXH
5785
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
| $40.1K | ﹤0.01% |
415
+48
| +13% | +$11.6K |
2023 Q3
2 quarters
|
|
5786
PUT
Blackstone Mortgage Trust
BXMT
$1.86B
| $39.8K | ﹤0.01% |
+2,000
| New | +$40.3K |
2024 Q1
0 quarters
|
|
|
SGI
5787
CALL
Somnigroup International
SGI
$14.3B
| $39.8K | ﹤0.01% |
700
-5,600
| -89% | -$292K |
2023 Q4
1 quarter
|
|
5788
CALL
Box
BOX
$4.85B
| $39.6K | ﹤0.01% |
1,400
-4,100
| -75% | -$110K |
2023 Q2
3 quarters
|
|
5789
Rani Therapeutics
RANI
$89.4M
| $39.5K | ﹤0.01% |
12,686
+8,988
| +243% | +$30.9K |
2021 Q4
9 quarters
|
|
5790
ProShares Ultra Gold
UGL
$734M
| $39.2K | ﹤0.01% |
2,172
+432
| +25% | +$6.87K |
2023 Q2
3 quarters
|
|
|
ASRT
5791
DELISTED
Assertio
ASRT
| $38.9K | ﹤0.01% |
2,705
-1,399
| -34% | -$19.1K |
2015 Q4
33 quarters
|
|
|
GRIN
5792
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $38.7K | ﹤0.01% |
3,660
-123
| -3% | -$1.15K |
2018 Q3
22 quarters
|
|
5793
PUT
FirstEnergy
FE
$25.3B
| $38.6K | ﹤0.01% |
+1,000
| New | +$37.4K |
2024 Q1
0 quarters
|
|
5794
State Street SPDR Dow Jones International Real Estate ETF
RWX
$239M
| $38.6K | ﹤0.01% |
1,480
-10,094
| -87% | -$259K |
2014 Q4
37 quarters
|
|
|
AJXA
5795
DELISTED
Great Ajax Corp.7.25% Convertible Senior Notes due 2024
AJXA
| $38.6K | ﹤0.01% |
1,550
| – | – |
2023 Q4
1 quarter
|
|
5796
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$153M
| $38.6K | ﹤0.01% |
448
+36
| +9% | +$3.28K |
2021 Q1
12 quarters
|
|
|
EVE.WS
5797
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
| – | – |
0
| – | – |
2023 Q2
3 quarters
|
|
5798
Invesco Variable Rate Investment Grade ETF
VRIG
$1.85B
| $38.4K | ﹤0.01% |
+1,531
| New | +$38.4K |
2024 Q1
0 quarters
|
|
5799
Vor Biopharma
VOR
$1.1B
| $38.4K | ﹤0.01% |
809
-416
| -34% | -$18.3K |
2021 Q1
12 quarters
|
|
5800
Traeger
COOK
$150M
| $38.3K | ﹤0.01% |
303
-153
| -34% | -$17.4K |
2021 Q3
10 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.